Category: StrideBio
-
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
StrideBio, Inc, a leading developer of novel engineered adeno-associated virus (AAV) based gene therapies, today announced the appointment of William (Bill) Monteith as Chief Operating Officer.